Related Experiment Videos
Embolization and postinfarction nephrectomy in patients with primary metastatic renal adenocarcinoma
K H Kurth1, F M Debruyne, R R Hall
1Department of Urology, Rotterdam, The Netherlands.
European Urology
|January 1, 1987
Abstract:
In a phase-II study of the EORTC GU Group 34 patients with metastatic renal cell carcinoma were treated by angioinfarction and delayed nephrectomy. The mortality of the procedure was 5.8%. One patient had a complete remission. 80% of the patients showed progression within 6 months after nephrectomy. The median survival of the patients was 25 weeks, 65% of the patients died within 1 year after nephrectomy.